The Use of Oral Beta-Blockers and Clinical Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes: a Long-Term Follow-Up Study.


Journal Article

BACKGROUND: The role of beta-blockers in patients with acute coronary syndromes is mainly derived from studies including patients with ST-segment elevation myocardial infarction. Little is known about the use of beta-blockers and associated long-term clinical outcomes in patients with non-ST-elevation acute coronary syndromes (NSTEACS). METHODS: We analyzed short- and long-term clinical outcomes of 2921 patients with NSTEACS using or not oral beta-blockers in the first 24 h of the acute coronary syndromes (ACS) presentation. The association between beta-blocker use and mortality was assessed using a propensity score adjusted analysis (N = 1378). RESULTS: Patients starting oral beta-blockers in the first 24 h of hospitalization, compared with patients who did not, had lower rates of in-hospital mortality (OR = 0.52, 95% CI 0.33 to 0.74, P = 0.002) and higher mean survival times in the long-term follow-up (11.86±0.4 years vs. 9.92±0.39 years, P < 0.001). CONCLUSION: The use of beta-blockers in the first 24 h of patients presenting with NSTEACS was associated with better in-hospital and long-term mortality outcomes.

Full Text

Duke Authors

Cited Authors

  • Nicolau, JC; Furtado, RHM; Baracioli, LM; Lara, LM; Dalçóquio, TF; Scanavini Junior, MA; Pereira, CAC; Lima, VM; Gonçalves, TM; Colodetti, R; Ferrari, AG; Lopes, RD; Giugliano, RP

Published Date

  • October 2018

Published In

Volume / Issue

  • 32 / 5

Start / End Page

  • 435 - 442

PubMed ID

  • 30128818

Pubmed Central ID

  • 30128818

Electronic International Standard Serial Number (EISSN)

  • 1573-7241

Digital Object Identifier (DOI)

  • 10.1007/s10557-018-6818-6


  • eng

Conference Location

  • United States